Renaissance Technologies - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 28 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$310
-14.4%
108,766
+18.5%
0.00%
Q1 2023$362
+36.1%
91,800
+36.6%
0.00%
Q4 2022$266
-99.8%
67,200
+154.5%
0.00%
Q3 2021$151,000
-74.5%
26,400
-75.5%
0.00%
-100.0%
Q2 2021$592,000
-52.8%
107,554
-50.3%
0.00%
-50.0%
Q1 2021$1,253,000
+14.0%
216,400
+32.0%
0.00%
+100.0%
Q4 2020$1,099,000
+890.1%
164,000
+986.1%
0.00%
Q3 2020$111,000
+484.2%
15,100
+47.4%
0.00%
Q1 2020$19,00010,2420.00%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 2,530,585$16,955,0000.73%
Ikarian Capital, LLC 1,836,545$12,305,0000.54%
Boxer Capital, LLC 2,477,194$16,597,0000.53%
RTW INVESTMENTS, LP 4,315,102$28,911,0000.48%
RA Capital Management 2,327,714$15,596,0000.22%
Orbimed Advisors 2,493,109$16,704,0000.15%
PURA VIDA INVESTMENTS, LLC 450,000$3,015,0000.11%
SUVRETTA CAPITAL MANAGEMENT, LLC 851,291$5,704,0000.08%
Anson Funds Management LP 50,113$336,0000.07%
Tekla Capital Management LLC 253,610$1,699,0000.06%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders